The BalancedInvestor Club

Drug Manufacturers Specialty Generic Industry Analysis

89 companies analyzed • Returns from -337.4% to +357.4%

Company List (89 Results)

View:
Sort:

Industry Performance

(89/89 companies)
2025-06-18 → 2026-06-16
Weighted Avg
-4.0%
Best
+357.4%
Worst
-337.4%
Returns Distribution
Top 5
1. ASRT+357.4%2. IXHL+281.5%3. AKAN+268.7%4. TLRY+254.4%5. FLGC+192.4%
Bottom 5
1. BGM-337.4%2. IMCC-243.2%3. ZYBT-226.2%4. ALVOW-160.3%5. SBFMW-142.8%

ASRT

+357.4%

Assertio Therapeutics Inc

IXHL

+281.5%

Incannex Healthcare Ltd ADR

AKAN

+268.7%

Akanda Corp

TLRY

+254.4%

Tilray Inc

FLGC

+192.4%

Flora Growth Corp

SCYX

+170.4%

Scynexis Inc

IRWD

+165.6%

Ironwood Pharmaceuticals Inc

BIOA

+154.1%

BioAge Labs, Inc

EVOK

+139.4%

Evoke Pharma Inc

CABR

+119.7%

Caring Brands Inc

ESPR

+105.5%

Esperion Therapeutics Inc

INDV

+100.6%

Indivior PLC Ordinary Shares

ETON

+85.9%

Eton Pharmaceuticals Inc

AVDL

+84.2%

Avadel Pharmaceuticals PLC

TXMD

+75.2%

TherapeuticsMD Inc

AMRX

+71.6%

Amneal Pharmaceuticals, Inc. Class A Common Stock

TEVA

+65.7%

Teva Pharma Industries Ltd ADR

TLPH

+63.7%

Talphera Inc.

UTHR

+63.1%

United Therapeutics Corporation

KNSA

+62.7%

Kiniksa Pharmaceuticals Ltd

1–20 of 89
Page 1 of 5
Methodology

The Weighted Average return (-4.0%) is calculated using market capitalization as weights. This gives larger companies more influence on the average, providing a more market-representative view.

85 companies with market cap data included: ASRT, IXHL, AKAN, TLRY, FLGC, SCYX, IRWD, BIOA, EVOK, CABR and 75 more...

We're educators, not advisors. We don't make buy or sell recommendations under any circumstance. All content is for educational purposes. Past performance doesn't guarantee future results. Your decisions are your own. Disclaimer